Raymond James Financial Services Advisors Inc. raised its position in National Health Investors, Inc. (NYSE:NHI – Get Rating) by 593.8% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 43,896 shares of the real estate investment trust’s stock after buying an additional 37,569 shares during the period. Raymond James Financial Services Advisors Inc. owned about 0.10% of National Health Investors worth $2,292,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in NHI. State Street Corp increased its holdings in National Health Investors by 15.9% in the first quarter. State Street Corp now owns 2,186,194 shares of the real estate investment trust’s stock valued at $130,904,000 after buying an additional 299,737 shares in the last quarter. Millennium Management LLC increased its position in shares of National Health Investors by 7,218.8% in the 2nd quarter. Millennium Management LLC now owns 258,574 shares of the real estate investment trust’s stock valued at $15,672,000 after purchasing an additional 255,041 shares during the last quarter. Mesirow Institutional Investment Management Inc. purchased a new stake in shares of National Health Investors in the 3rd quarter valued at approximately $7,169,000. Prudential Financial Inc. increased its position in shares of National Health Investors by 271.9% in the 3rd quarter. Prudential Financial Inc. now owns 160,057 shares of the real estate investment trust’s stock valued at $9,049,000 after purchasing an additional 117,015 shares during the last quarter. Finally, Barclays PLC grew its position in shares of National Health Investors by 154.0% in the 3rd quarter. Barclays PLC now owns 157,937 shares of the real estate investment trust’s stock valued at $8,928,000 after buying an additional 95,768 shares during the last quarter. Hedge funds and other institutional investors own 62.44% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms have recently commented on NHI. StockNews.com assumed coverage on shares of National Health Investors in a research note on Thursday, May 18th. They issued a “hold” rating for the company. Credit Suisse Group reduced their target price on shares of National Health Investors from $55.00 to $50.00 and set a “neutral” rating on the stock in a research report on Wednesday, March 29th. Finally, Wells Fargo & Company assumed coverage on shares of National Health Investors in a research note on Wednesday, April 19th. They set an “equal weight” rating and a $52.00 target price for the company. Five equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $57.80.
National Health Investors Stock Up 0.7 %
National Health Investors Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 4th. Shareholders of record on Friday, June 30th will be issued a dividend of $0.90 per share. The ex-dividend date of this dividend is Thursday, June 29th. This represents a $3.60 annualized dividend and a yield of 6.88%. National Health Investors’s dividend payout ratio is currently 173.08%.
About National Health Investors
National Health Investors, Inc engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. It operates through the Real Estate Investments and Senior Housing Operating Portfolio (SHOP) segments. The Real Estate Investments segment includes real estate investments and lease, mortgage, and other notes receivables in independent living facilities.
- Get a free copy of the StockNews.com research report on National Health Investors (NHI)
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.